Further, sEH has been associated with, and the inhibition of its activity has been proposed as a treatment target for, diseases of the brain, including dementias [9,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40]. The gene discussed is EPHX2; the disease is dementia.